Navigation Links
China Biologic Products to Report Fourth Quarter and Fiscal Year 2012 Financial Results

BEIJING, March 8, 2013  /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release fourth quarter and fiscal year 2012 financial results on Wednesday, March 13, 2013 after the market closes.

The Company's management will hold a conference call at 8:00 a.m. ET on Thursday, March 14, 2013 to discuss fourth quarter and fiscal year 2012 results. Listeners may access the call by dialing:U.S. toll free:

+1 866 978 9970U.K. toll free:

+0 800 279 7785Mainland China toll free (landline):

800 803 6103Mainland China toll free (mobile):

400 681 6405Hong Kong toll free:

3027 5500International toll:

+852 3027 5500Conference ID:

674 477#A telephone replay will become available beginning two hours after the conclusion of the call and will remain available through March 20, 2013. Listeners may access the replay by dialing:

U.S. toll free:

+1 866 753 0743U.K. toll free:

+0 808 234 7126Mainland China:

800 876 5016Hong Kong:

3027 5520International toll:

+852 3027 5520Conference ID:

138 012# About China Biologic Products, Inc.China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. The Company also has an equity investment in Xi'an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and other healthcare facilities in China. For additional information, please see the Company's website

Contact: China Biologic Products, Inc.
Mr. Ming Yin
Vice President
Phone: +86-10-6598-3099

ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191

SOURCE China Biologic Products, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. China Botanic Pharmaceutical Inc. Announces Acceptance of its Plan of Compliance by NYSE MKT LLC
2. Marken Opens Pharmaceutical Depot In Beijing China
3. Leica Biosystems and Dell Enable Access to Pathology Images Between China and the U.S.
4. China Nepstar Chain Drugstore to Report Fourth Quarter and Fiscal Year 2012 Financial Results on March 28, 2013
5. China pharmaceutical manufacturing industry, 2013
6. Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures
7. Quality by Design China 2013 is coming up soon
8. China Botanic Pharmaceutical Inc. Announces Receipt of Notice of Failure to Satisfy Continued Listing Requirements
9. Monoclonal Antibody Industry 2013 Global and China Market Analysis in New Research Report at
10. Pressure Relief Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
11. Research on Chinas Animal Vaccine Industry, 2013-2017
Post Your Comments:
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):